References
- Wiedenmayer KA, Weiss S, Chattopadhyay C, Mukherjee A, Kundu R, Aye R, Tediosi F, Hetzel MW, Tanner M. Simplifying paediatric immunization with a fully liquid DTP-HepB-Hib combination vaccine: evidence from a comparative time-motion study in India. Vaccine 2009; 27(5):655–59; PMID:19056443; http://dx.doi.org/10.1016/j.vaccine.2008.11.045
- Insel RA. Potential alterations in immunogenicity by combining or simultaneously administering vaccine components. Ann N Y Acad Sci. 1995; 764:158–69; PMID:7486516; http://dx.doi.org/10.1111/j.1749-6632.1995.tb55820.x
- Rao R, Dhingra MS, Bavdekar S, Behera N, Daga SR, Dutta AK, Kundu R, Maiya PP, Mishra P, Shah R, et al. A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (liq) and TritanrixHB + Hiberix (lyo) in Indian infants administered according to the EPI schedule. Hum Vaccines 2009; 5(6):1–5; PMID:19333002; http://dx.doi.org/10.4161/hv.5.6.7816
- Sharma HJ, Yadav S, Lalwani SK, Kapre SV, Jadhav SS, Charkravarty A, Parekh SS, Palkar S, Bhardwaj SH, Namjoshi GS, et al. Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children. Hum Vaccines 2011; 7(4):451–57; PMID:21403463; http://dx.doi.org/10.4161/hv.7.4.14208
- Ali SS, Chandrashekar SR, Singh M, Bansal RK, Sharma DR, Arora D. A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine). Hum Vaccines 2007; 3(4):116–21; PMID:17617743; http://dx.doi.org/10.4161/hv.3.4.4061
- Sharma H, Yadav S, Lalwani S, Gupta V, Kapre S, Jadhav S, Charkravarty A, Parekh SS, Palkar S. A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants. Vaccine 2011; 29:2359–64; PMID:21288803; http://dx.doi.org/10.1016/j.vaccine.2011.01.054
- Dhingra MS, Rao R, Bhat S, Joshi R, Kalra V, Parikh HR, Rao SN, Sethi GR, Shah N, Muzaffaruddin M. Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with Easyfour in Indian infants administered per EPI schedule: A phase III trial. Hum Vaccines 2010; 6(7):572–7; PMID:20421723; http://dx.doi.org/10.4161/hv.6.7.11817
- World Health Organization. Hepatitis B vaccines WHO position paper. Weekly Epidemiological Record 2009; 84(40):405–20; PMID:19817017
- World Health Organization. Diphtheria vaccine WHO position paper. Weekly Epidemiological Record 2006; 81(3):21–32; PMID:16671238
- World Health Organization. Tetanus vaccine WHO position paper. Weekly Epidemiological Record 2006; 81(20):197–208; PMID:16710949
- World Health Organization. Pertussis vaccines WHO position paper. Weekly Epidemiological Record 2010; 85(40):385–400; PMID:20939150
- World Health Organization. Haemophilus influenzae type b conjugate vaccines WHO Position Paper. Weekly Epidemiological Record 2006; 81(47):445–452; PMID:17124755
- Bonhoeffer J, Bentsi-Enchill A, Chen RT, Fisher MC, Gold MS, Hartman K, Heininger U, Hoet B, Jefferson T, Khuri-Bulos N, et al. Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies. Vaccine 2009; 27(16):2282–8; PMID:19056451; http://dx.doi.org/10.1016/j.vaccine.2008.11.036